Hudson Bay Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hudson Bay Capital Management's AMGN Position: Q3 2025 in Review
Hudson Bay Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 8,561 shares — an estimated $2.39M sold.
Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and held it in 11 quarters. The position peaked at $54.6M in Q4 2022. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Hudson Bay Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Hudson Bay Capital Management sold 8,561 Amgen shares in Q3 2025, an estimated $2.39M.
- Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and held it in 11 quarters.
- Hudson Bay Capital Management's Amgen position peaked at $54.6M in Q4 2022.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.